Plexus Announces Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results

Rhea-AI Summary

Plexus (NASDAQ: PLXS) reported fiscal Q4 (ended Sep 27, 2025) revenue of $1.058B, GAAP diluted EPS of $1.87 and non-GAAP diluted EPS of $2.14. Fiscal 2025 revenue was $4.033B with GAAP EPS $6.26 and non-GAAP EPS $7.43. Q4 free cash flow was $97M; FY2025 free cash flow was $154M. ROIC was 14.6% producing an economic return of 5.7% above WACC. The company repurchased $65M of shares in FY2025 and repurchased $21.5M in Q4; $85M remains under the $100M authorization. Q1 FY2026 guidance: revenue $1.050B–$1.090B and non-GAAP EPS $1.66–$1.81.

Positive

• Fiscal 2025 revenue of $4.033B
• FY2025 free cash flow of $154M
• ROIC of 14.6% (economic return +5.7% above WACC)
• Generated $941M annualized revenue from 141 new program wins in FY2025
• Share repurchases of $65M in FY2025 with $85M remaining authorization

Negative

• Company guidance expects FY2026 free cash flow of ~$100M (down vs FY2025 $154M)
• Europe, Middle East & Africa revenue for FY2025 fell to $440M from $538M (≈18% decline)
• Top 10 customers comprised 49% of Q4 revenue, indicating customer concentration risk

News Market Reaction – PLXS

+2.57%

1 alert

+2.57% News Effect

+$99M Valuation Impact

$3.94B Market Cap

1.4x Rel. Volume

On the day this news was published, PLXS gained 2.57%, reflecting a moderate positive market reaction. This price movement added approximately $99M to the company's valuation, bringing the market cap to $3.94B at that time.

Data tracked by StockTitan Argus on the day of publication.

NEENAH, WI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal fourth quarter and fiscal year ended September 27, 2025, and guidance for our fiscal first quarter ending January 3, 2026.

• Reports fiscal fourth quarter revenue of $1.058 billion, GAAP operating margin of 5.0% and GAAP diluted EPS of $1.87.
• Reports fiscal 2025 revenue of $4.033 billion, GAAP operating margin of 5.0% and GAAP diluted EPS of $6.26.
• Reports fiscal fourth quarter non-GAAP operating margin of 5.8% and non-GAAP diluted EPS of $2.14, excluding $0.27 of stock-based compensation expense.
• Reports fiscal 2025 non-GAAP operating margin of 5.9% and non-GAAP diluted EPS of $7.43, excluding $1.02 of stock-based compensation expense and $0.15 of restructuring and other charges.
• Initiates fiscal first quarter 2026 revenue guidance of $1.050 billion to $1.090 billion with GAAP diluted EPS of $1.40 to $1.55, including $0.26 of stock-based compensation expense. Fiscal first quarter non-GAAP EPS guidance of $1.66 to $1.81 excludes stock-based compensation expense.
  
  

		Three Months Ended
		Sep 27, 2025		Sep 27, 2025		Jan 3, 2026
		Q4F25 Results		Q4F25 Guidance		Q1F26 Guidance
Summary GAAP Items
Revenue (in billions)		$1.058		$1.025 to $1.065		$1.050 to $1.090
Operating margin		5.0%		5.0% to 5.4%		4.9% to 5.3%
Diluted EPS		$1.87		$1.57 to $1.72		$1.40 to $1.55
Summary Non-GAAP Items (1)
Adjusted operating margin (2)		5.8%		5.7% to 6.1%		5.6% to 6.0%
Adjusted EPS (3)		$2.14		$1.82 to $1.97		$1.66 to $1.81
Return on invested capital (ROIC)		14.6%
Economic return		5.7%
(1)	Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.
(2)	Excludes stock-based compensation expense of approximately 80 bps for Q4F25 results as well as 70 bps for Q4F25 guidance and Q1F26 guidance.
(3)	Excludes stock-based compensation expense, net of tax, of $0.27 for Q4F25 results, $0.25 for Q4F25 guidance and $0.26 for Q1F26 guidance.

Fiscal Fourth Quarter 2025 Information

• Won 28 manufacturing programs representing $274 million in annualized revenue when fully ramped into production.
• Generated free cash flow of $97 million.
• Purchased $21.5 million of our shares at an average price of $134.07 per share under our share repurchase programs. Under our current $100.0 million repurchase authorization, $85.0 million remains available.
  
  

Fiscal Year 2025 Information

• Generated free cash flow of $154 million.
• Produced ROIC of 14.6%, representing an economic return of 570 basis points above our weighted average cost of capital of 8.9%.
• Purchased $65.0 million of our shares at an average price of $136.80 per share.
  
  

Todd Kelsey, President and Chief Executive Officer, commented, “The Plexus team continues to deliver a differentiated value proposition for our customers, and generated strong fiscal fourth quarter results. I am particularly pleased with our non-GAAP EPS of $2.14, which exceeded guidance, and our free cash flow, which again exceeded projections.”

Mr. Kelsey continued, “Our go-to-market team generated 28 fiscal fourth quarter manufacturing wins, representing $274 million in annualized revenue. For fiscal 2025, the team generated 141 manufacturing wins representing $941 million in annualized revenue, which supports revenue growth exceeding that of our end markets. In addition, efforts to diversify our engineering solutions engagements successfully drove increased wins for fiscal 2025, while our sustaining services team achieved record wins for the fiscal year.”

Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, "For the seventh consecutive quarter, our team drove a reduction in our gross inventory balance, ending the fiscal year $82 million lower than fiscal 2024. Fiscal fourth quarter cash cycle of 63 days was favorable to our expectations and sequentially lower by 6 days as we benefited from increased revenue and continued progress on our working capital initiatives. This level of cash cycle was the best result delivered in the past five years. Our favorable cash cycle combined with our strong operating performance produced fiscal 2025 return on invested capital of 14.6%, which exceeded our cost of capital by 570 basis points."

Mr. Jermain continued, "We delivered $154 million in free cash flow for fiscal 2025, a result well above our projections. Utilizing our exceptional free cash flow, we continued to execute upon our expanded share repurchase program and reduce our borrowing, ending the year in a net cash position. Finally, while we expect increased investments in support of future revenue growth and operational efficiency initiatives, we anticipate delivering robust fiscal 2026 free cash flow of approximately $100 million and deploying excess cash to create additional shareholder value."

Mr. Kelsey added, “We remain dedicated to our Plexus Value of Innovating Responsibly to help create the products that build a better world. For fiscal 2025, our global team contributed more than 32,000 paid volunteer hours to our local communities, a 47% year-over-year increase, Plexus donated $1.4 million to global non-profits through our Plexus Community Foundation and our team reduced waste to landfill by more than 30% globally, with eight Plexus sites now operating at zero waste to landfill. In addition, we reduced our absolute Scope 1 and 2 emissions by more than 10% across our global manufacturing sites versus our fiscal 2023 baseline.”

Mr. Kelsey continued, “We are guiding fiscal first quarter revenue of $1.050 to $1.090 billion, non-GAAP operating margin of 5.6% to 6.0% and non-GAAP EPS of $1.66 to $1.81. New program ramps, inclusive of share gains, continue to drive our revenue growth in excess of modest end-market growth. In addition, during the fiscal first quarter, we will continue to invest in talent, technology, facilities and advanced capabilities to expand our industry-leading solutions, drive greater long-term operational efficiency and prepare for expected fiscal 2026 revenue growth.”

Mr. Kelsey concluded, “Fiscal 2025 was an outstanding year for Plexus. Our team delivered excellent operational execution, strong financial performance, including 40 basis points of non-GAAP operating margin expansion and 30% non-GAAP EPS growth, and robust and well-balanced new program wins across our solutions. These results provide momentum and position us well in fiscal 2026 to accelerate revenue growth toward our 9% to 12% goal and sustain strong financial performance.”

Quarterly & Annual Comparison	Three Months Ended												Twelve Months Ended
(in thousands, except EPS)	Sep 27, 2025				Jun 28, 2025				Sep 28, 2024				Sep 27, 2025				Sep 28, 2024
Revenue	$	1,058,366			$	1,018,308			$	1,050,569			$	4,032,966			$	3,960,827
Gross profit		104,783				103,288				107,912				406,514				378,530
Operating income		53,112				53,608				53,858				202,371				167,732
Net income		51,429				45,116				41,221				172,885				111,815
Diluted EPS	$	1.87			$	1.64			$	1.48			$	6.26			$	4.01
Gross margin		9.9	%			10.1	%			10.3	%			10.1	%			9.6	%
Operating margin		5.0	%			5.3	%			5.1	%			5.0	%			4.2	%
ROIC (1)		14.6	%			14.1	%			11.8	%			14.6	%			11.8	%
Economic return (1)		5.7	%			5.2	%			3.6	%			5.7	%			3.6	%
(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.

Business Segment and Market Sector Revenue

Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised 49% of revenue during the fourth quarter of fiscal 2025. This is up 1 percentage point from the third quarter of fiscal 2025 and down 3 percentage points from the fourth quarter of fiscal 2024. For fiscal 2025, top 10 customers comprised 49% of revenue, up 1 percentage point from fiscal 2024.

Business Segments ($ in millions)	Three Months Ended												Twelve Months Ended
	Sep 27, 2025				Jun 28, 2025				Sep 28, 2024				Sep 27, 2025				Sep 28, 2024
Americas	$	336			$	312			$	307			$	1,217			$	1,219
Asia-Pacific		605				594				618				2,393				2,213
Europe, Middle East and Africa		119				117				128				440				538
Elimination of inter-segment sales		(2	)			(5	)			(2	)			(17	)			(9	)
Total Revenue	$	1,058			$	1,018			$	1,051			$	4,033			$	3,961

Market Sectors ($ in millions)	Three Months Ended															Twelve Months Ended
	Sep 27, 2025					Jun 28, 2025					Sep 28, 2024					Sep 27, 2025					Sep 28, 2024
Aerospace/Defense	$	173	16	%		$	183	18	%		$	184	18	%		$	689	17	%		$	698	19	%
Healthcare/Life Sciences		424	40	%			420	41	%			415	39	%			1,629	40	%			1,555	38	%
Industrial		461	44	%			415	41	%			452	43	%			1,715	43	%			1,708	43	%
Total Revenue	$	1,058				$	1,018				$	1,051				$	4,033				$	3,961

Non-GAAP Supplemental Information

Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.

ROIC and Economic Return

ROIC for fiscal year 2025 was 14.6%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a five-quarter period for the fiscal year. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Plexus' weighted average cost of capital for fiscal 2025 was 8.9%. ROIC for fiscal year 2025 less Plexus’ weighted average cost of capital resulted in an economic return of 5.7%.

Free Cash Flow

Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended September 27, 2025, cash flows provided by operations was $132.0 million, less capital expenditures of $34.8 million, resulting in free cash flow of $97.2 million. For the fiscal year ended September 27, 2025, cash flows provided by operations was $249.2 million, less capital expenditures of $95.2 million, resulting in free cash flow of $154.0 million.

Cash Cycle Days		Three Months Ended
		Sep 27, 2025		Jun 28, 2025		Sep 28, 2024
Days in Accounts Receivable		57		59		54
Days in Contract Assets		13		13		10
Days in Inventory		118		128		127
Days in Accounts Payable		(70)		(72)		(59)
Days in Advanced Payments		(55)		(59)		(68)
Annualized Cash Cycle (1)		63		69		64
(1)	Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.

Conference Call and Webcast Information

What:	Plexus Fiscal Q4 and Fiscal Year 2025 Earnings Conference Call and Webcast
When:	Thursday, October 23, 2025 at 8:30 a.m. Eastern Time
Where:	Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below: Webcast link: https://events.q4inc.com/attendee/727582481
Replay:	The webcast will be archived on the Plexus website and will be available as on-demand for 12 months

Investor and Media Contact
Shawn Harrison        
+1.920.969.6325
shawn.harrison@plexus.com

About Plexus
Since 1979, Plexus has helped create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 26 facilities in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions. For more information about Plexus, visit our website at www.plexus.com.

Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, conflict in the Middle East, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2024 Form 10-K.

PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
	Three Months Ended								Twelve Months Ended
	Sep 27,				Sep 28,				Sep 27,				Sep 28,
		2025				2024				2025				2024
Net sales	$	1,058,366			$	1,050,569			$	4,032,966			$	3,960,827
Cost of sales		953,583				942,657				3,626,452				3,582,297
Gross profit		104,783				107,912				406,514				378,530
Operating expenses:
Selling and administrative expenses		51,671				54,054				199,460				190,541
Restructuring and other charges, net		—				—				4,683				20,257
Operating income		53,112				53,858				202,371				167,732
Other income (expense):
Interest expense		(2,413	)			(5,577	)			(11,605	)			(28,876	)
Interest income		883				1,220				3,922				3,860
Miscellaneous, net		(1,917	)			(4,087	)			(6,670	)			(13,184	)
Income before income taxes		49,665				45,414				188,018				129,532
Income tax (benefit) expense		(1,764	)			4,193				15,133				17,717
Net income	$	51,429			$	41,221			$	172,885			$	111,815
Earnings per share:
Basic	$	1.91			$	1.52			$	6.39			$	4.08
Diluted	$	1.87			$	1.48			$	6.26			$	4.01
Weighted average shares outstanding:
Basic		26,901				27,203				27,038				27,397
Diluted		27,444				27,783				27,616				27,909

PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
(unaudited)
	Sep 27,				Sep 28,
		2025				2024
ASSETS
Current assets:
Cash and cash equivalents	$	306,464			$	345,109
Restricted cash		294				2,353
Accounts receivable		656,573				622,366
Contract assets		150,654				120,560
Inventories		1,229,839				1,311,434
Prepaid expenses and other		54,969				75,328
Total current assets		2,398,793				2,477,150
Property, plant and equipment, net		546,052				501,112
Operating lease right-of-use assets		72,863				74,360
Deferred income taxes		91,349				73,919
Other assets		28,053				27,280
Total non-current assets		738,317				676,671
Total assets	$	3,137,110			$	3,153,821
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt and finance lease obligations	$	45,793			$	157,325
Accounts payable		726,597				606,378
Advanced payments from customers		575,850				709,152
Accrued salaries and wages		109,076				94,448
Other accrued liabilities		61,367				75,991
Total current liabilities		1,518,683				1,643,294
Long-term debt and finance lease obligations, net of current portion		91,987				89,993
Accrued income taxes payable		—				17,198
Long-term operating lease liabilities		29,422				32,275
Deferred income taxes		6,000				8,234
Other liabilities		36,430				38,002
Total non-current liabilities		163,839				185,702
Total liabilities		1,682,522				1,828,996
Shareholders’ equity:
Common stock		547				545
Additional paid-in-capital		695,653				680,638
Common stock held in treasury		(1,255,451	)			(1,190,115	)
Retained earnings		1,996,028				1,823,143
Accumulated other comprehensive income		17,811				10,614
Total shareholders’ equity		1,454,588				1,324,825
Total liabilities and shareholders’ equity	$	3,137,110			$	3,153,821

PLEXUS CORP. AND SUBSIDIARIES
NON-GAAP SUPPLEMENTAL INFORMATION Table 1
(in thousands, except per share data)
(unaudited)
		Three Months Ended												Twelve Months Ended
		Sep 27,				Jun 28,				Sep 28,				Sep 27,				Sep 28,
		2025				2025				2024				2025				2024
Operating income, as reported		$	53,112			$	53,608			$	53,858			$	202,371			$	167,732
Operating margin, as reported			5.0	%			5.3	%			5.1	%			5.0	%			4.2	%
Non-GAAP adjustments:
Restructuring costs (1)		—				—				—				4,683				22,507
Other non-recurring income (2)		—				—				—				—				(2,250		)
Stock-based compensation		7,803				7,691				10,849				29,616				30,485
Non-GAAP operating income		$	60,915			$	61,299			$	64,707			$	236,670			$	218,474
Non-GAAP operating margin			5.8	%			6.0	%			6.2	%			5.9	%			5.5	%
Net income, as reported		$	51,429			$	45,116			$	41,221			$	172,885			$	111,815
Non-GAAP adjustments:
Restructuring costs, net of tax (1)		—				—				—				4,191				20,144
Other non-recurring income, net of tax (2)		—				—				—				—				(2,014		)
Stock-based compensation, net of tax		7,414				7,307				10,306				28,136				29,582
Adjusted net income		$	58,843			$	52,423			$	51,527			$	205,212			$	159,527
Diluted earnings per share, as reported		$	1.87			$	1.64			$	1.48			$	6.26			$	4.01
Non-GAAP per share adjustments:
Restructuring costs, net of tax (1)		—				—				—				0.15				0.72
Other non-recurring income, net of tax (2)		—				—				—				—				(0.07		)
Stock-based compensation, net of tax		0.27				0.26				0.37				1.02				1.06
Adjusted diluted earnings per share		$	2.14			$	1.90			$	1.85			$	7.43			$	5.72

(1)	During the twelve months endedSeptember 27, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company’s workforce in the EMEA and AMER regions. During the twelve months ended September 28, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.
(2)	During the twelve months ended September 28, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.

PLEXUS CORP. AND SUBSIDIARIES
NON-GAAP SUPPLEMENTAL INFORMATION Table 2
(in thousands)
(unaudited)
ROIC and Economic Return Calculations	Twelve Months Ended					Nine Months Ended					Twelve Months Ended
	Sep 27,					Jun 28,					Sep 28,
	2025					2025					2024
Operating income, as reported		$	202,371				$	149,259				$	167,732
Restructuring and other charges, net			4,683					4,683					20,257
Accelerated stock-based compensation (1)	+		—			+		—			+		5,063
Adjusted operating income		$	207,054				$	153,942				$	193,052
						÷		3
							$	51,314
						x		4
Adjusted annualized operating income		$	207,054				$	205,256				$	193,052
Adjusted effective tax rate	x		8	%		x		11	%		x		13	%
Tax impact			16,564					22,578					25,097
Adjusted operating income (tax-effected)		$	190,490				$	182,678				$	167,955
Average invested capital	÷	$	1,303,575			÷	$	1,298,575			÷	$	1,418,698
ROIC			14.6	%				14.1	%				11.8	%
Weighted average cost of capital	-		8.9	%		-		8.9	%		-		8.2	%
Economic return			5.7	%				5.2	%				3.6	%

Average Invested Capital Calculations	Sep 27,				Jun 28,				Mar 29,				Dec 28,				Sep 28,
		2025				2025				2025				2024				2024
Equity	$	1,454,588			$	1,419,085			$	1,351,675			$	1,319,069			$	1,324,825
Plus:
Debt and finance lease obligations - current		45,793				50,678				121,014				121,977				157,325
Operating lease obligations - current (2)		8,253				8,470				9,968				14,875				14,697
Debt and finance lease obligations - long-term		91,987				92,215				88,761				88,728				89,993
Operating lease obligations - long-term		29,422				31,192				32,720				35,124				32,275
Less: Cash and cash equivalents		(306,464	)			(237,567	)			(310,531	)			(317,161	)			(345,109	)
	$	1,323,579			$	1,364,073			$	1,293,607			$	1,262,612			$	1,274,006

Average Invested Capital Calculations	Jun 29,				Mar 30,				Dec 30,				Sep 30,
		2024				2024				2023				2023
Equity	$	1,266,360			$	1,259,762			$	1,266,755			$	1,214,382
Plus:
Debt and finance lease obligations - current		258,175				245,964				251,119				240,205
Operating lease obligations - current (2)		7,990				8,281				9,172				8,363
Debt and finance lease obligations - long-term		90,715				192,025				192,118				190,853
Operating lease obligations - long-term		31,923				33,915				35,989				38,552
Less: Cash and cash equivalents		(269,868	)			(265,053	)			(231,982	)			(256,233	)
	$	1,385,295			$	1,474,894			$	1,523,171			$	1,436,122

(1)	During the twelve months ended September 28, 2024, $5.1 million of accelerated stock-based compensation expense was recorded in selling and administrative expense in the accompanying Condensed Consolidated Statements of Operations as a result of a previously announced executive retirement agreement.
(2)	Included in other accrued liabilities on the Condensed Consolidated Balance Sheets.

FAQ

What did Plexus (PLXS) report for fiscal Q4 2025 revenue and EPS on Oct 22, 2025?

Plexus reported fiscal Q4 revenue of $1.058 billion and GAAP diluted EPS of $1.87 (non-GAAP EPS $2.14).

What is Plexus (PLXS) fiscal 2025 free cash flow and ROIC reported Oct 22, 2025?

Fiscal 2025 free cash flow was $154 million and ROIC was 14.6%, producing an economic return of 5.7% above its WACC.

What guidance did Plexus (PLXS) give for fiscal Q1 2026 on Oct 22, 2025?

Plexus guided Q1 FY2026 revenue of $1.050B–$1.090B and non-GAAP EPS of $1.66–$1.81.

How much did Plexus (PLXS) repurchase in shares during fiscal 2025 and what remains authorized?

Plexus repurchased $65.0 million of shares in fiscal 2025 and repurchased $21.5 million in Q4; $85.0 million remains available under the $100.0 million authorization.

How significant were new program wins for Plexus (PLXS) in fiscal 2025?

Plexus recorded 141 manufacturing wins in fiscal 2025 representing $941 million of annualized revenue when fully ramped.